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Background: Madin Darby Canine Kidney (MDCK) cells form polarized epithelium in vitro and are routinely used in
research fields ranging from protein trafficking to influenza. However, the canine origin of these cells also means
that compared to man or mouse, genomic resources are more limited and performance of commercially available
antibodies often untested. The synthesis of pro-inflammatory prostaglandins in the kidney is mediated by the
constitutively expressed cyclooxygenase 1 and the inducible cyclooxygenase 2 (COX-1 and COX-2, respectively).
There are conflicting reports on the expression of COX-1 and COX-2 in MDCK cells and this lingering uncertainty
about such important pharmacological targets may affect the interpretation of results obtained from this cell line.
Results: In order to definitively settle the issue of cyclooxygenase expression in MDCK cells, we designed PCR
primers based on dog genomic sequences to probe COX-1 and COX-2 mRNA expression in MDCK cells and dog
kidney. We report that while COX-1 and COX-2 genes are both expressed in dog kidney, COX-1 expression is
undetectable in MDCK cells.
Conclusions: By improving the characterization of cyclooxygenase expression in MDCK cells, this study will
contribute to a better understanding of the properties of this cell line and lead to improved experimental designs
and data interpretations.
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Cyclooxygenases are important pharmacological targets,
as they are involved in the synthesis of pro-inflammatory
prostaglandins [1]. In addition to the constitutively
expressed cyclooxygenase 1 (COX-1), the inducible cy-
clooxygenase 2 (COX-2) is also robustly expressed in the
kidney where it plays a role in cellular adaptation to os-
motic stress [2,3].
Madin Darby Canine Kidney (MDCK) cells are easy to
grow and can form polarized epithelium in vitro. These
cells have been used notably in investigations on mem-
brane permeability and tight junctions, protein traffick-
ing, influenza viral infection [4] and phorbol ester-
induced inflammatory processes [5]. In the decade or so
between identification of the inducible COX-2 gene [6]
and sequencing of dog cyclooxygenases [7-10], studies
on their expression in MDCK cells assessed COX-1 and* Correspondence: guillaume_pelletier@hc-sc.gc.ca
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unless otherwise stated.COX-2 protein levels by Western blot [2,11-14] and
mRNA levels by Northern blot or RT-PCR [11,13,15,16],
see Table 1. These studies which were based on antibodies
raised against cyclooxygenases from other organisms or
on orthologous nucleotide sequences from different spe-
cies reached conflicting conclusions.
In order to definitively settle the issue of COX-1 and
COX-2 expression in MDCK cells, we designed PCR
primers based on published dog genomic and mRNA se-
quences retrieved from ENSEMBL (www.ensembl.org)
and NCBI (www.ncbi.nlm.nih.gov) databases for the
Prostaglandin G/H synthase 1 and 2 genes (PTGS1 and
PTGS2) coding for the COX-1 and COX-2 proteins, re-
spectively. These primers were then used for PCR ampli-
fication of mRNA and genomic DNA from MDCK cells
and dog kidney.
Results
The expression of COX-1 (PTGS1), COX-2 (PTGS2) and
HPRT1 (hypoxanthine phosphoribosyltransferase 1) genes
in MDCK cells and dog kidney were assessed underentral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Summary of cited studies on the expression of COX-1 and COX-2 in MDCK cells
Reference Summary of findings
Yang et al. [2] Western blot: COX-2 observed in control MDCK cells and strongly induced by hyperosmolarity. COX-1
expression was not detected in MDCK cells.
Schaeffers et al. [11] Western blot: COX-1 and COX-2 not detected in MDCK cells.
Northern blot (mouse probe): COX-1 and COX-2 not detected in MDCK cells.
RT-PCR (based on consensus sequence in mouse, rat and man): Lowly expressed COX-2 in control MDCK
cells is induced by TPA exposure. COX-1 expression not detected in control and TPA-treated MDCK cells.
Sciorra and Daniel [12] Western blot: Low COX-1 and COX-2 levels in Control MDCK cells and strong COX-2 (but not COX-1)
induction following TPA exposure.
Ostrom et al. [13] Western blot: COX-1 and COX-2 expressed in MDCK cells, but not induced by a variety of factors,
including TPA.
RT-PCR (based on conserved sequence across species): COX-2 transcript amplified, but not COX-1
(despite numerous attempts).
Benitah et al. [14] Western blot: COX-1 and COX-2 both detected in control MDCK cells.
Cowley et al. [15] Northern blot (mouse probe): COX-2 transcript present in control MDCK cells and quickly induced by
hyperosmolarity. COX-1 not detected in control MDCK cells but weak signal detected following chronic
hyperosmolarity. (Cross-hybridisation of cyclooxygenase probes was observed.)
Kay-Mugford et al. [16] Northern blot (human probe): COX-1 and COX-2 detected in MDCK cells.
RT-PCR (primers based on human sequence): COX-2 expression not detected in MDCK cells.
Knottenbelt et al. [17] Western blot: COX-1 and COX-2 not detected in MDCK cells.
Reyes-Martin et al. [18] Western blot: COX-1 and COX-2 both detected in control MDCK cells and strongly induced following
H2O2 exposure.
Flores-Benitez et al. [19] Western blot: COX-1 and COX-2 both detected in control MDCK cells, but not induced following
EGF treatment.
Steinert et al. [20] Western blot: COX-2 expressed in control MDCK cells and induced by hyperosmolarity.
Northern blot (human probe): COX-2 expressed in control MDCK cells and induced by hyperosmolarity.
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the housekeeping gene HPRT1 and COX-2 amplified their
target sequences from both dog kidney and MDCK cells
(Figure 1B). However, while the three primer sets for the
COX-1 gene successfully amplified their target sequences
from dog kidney mRNA, they failed to amplify mRNA
from MDCK cells (Figure 1B). Further PCR investigation
using Cox1_E4-5 primers (Table 2) to probe genomic
DNAs amplified a 380 bp fragment (including 212 bp of
COX-1 intronic sequences) from both dog kidney and
MDCK cells (Figure 1B). Hence, although COX-1 mRNA
is not detected in MDCK cells, COX-1 coding sequences
are present in MDCK genome and the exact reason be-
hind this lack of expression remains to be determined.
Discussion
Several research groups assessed COX-1 and COX-2 pro-
tein levels in MDCK cells by Western blot using anti-
bodies raised against protein epitopes from different
mammalian species, often leading to conflicting results
[2,11-14,17-20], see Table 1. Although the commercial
suppliers of the antibodies were generally mentioned, this
information was not always sufficient to identify the spe-
cific antibody used. This ambiguity on antibody identities,
along with the sometimes incomplete description of theMDCK strain used [4,21], hampered comparison between
these studies.
Prior to the availability of dog cyclooxygenase gene se-
quences, detection of COX-1 and COX-2mRNA expression
in MDCK cells relied on Northern blot using orthologous
human or mouse sequences as probes. These investigations
also reached differing conclusions [11,15,16] which may be
explained by non-specific cross-species hybridisation of the
probes. Efforts to assess COX-1 gene expression in MDCK
cells by RT-PCR proved unsuccessful [11,13]. Although ab-
errant cyclooxygenase expression in MDCK cells was sug-
gested [16], incomplete knowledge of the dog genome at
that time prevented a definitive conclusion.
In this report, our attempts to amplify COX-1 mRNA
from MDCK cells using three different sets of PCR
primers designed from dog genomic sequences and cov-
ering different regions of the COX-1 gene (Figure 1A)
also failed (Figure 1B). The same primer sets were suc-
cessfully used to amplify their respective targets from
dog kidney mRNA, as confirmed by sequencing of the
amplicons generated. In light of a report on COX-1 pro-
tein induction in MDCK cells [18], we also assessed
COX-1 expression in MDCK cells exposed to 12-O-
tetradecanoylphorbol-13-acetate (TPA) as described in
[22], failing again to detect any expression (data not
Figure 1 Expression of cyclooxygenases in MDCK cells and dog kidney. A) Schematic representation of the exonic structure of the
PTGS1 transcript (coding for the COX-1 protein) in dog, mouse, rat and human. Exon structure and alignment were based on NCBI RefSeq
NM_001003023, NM_08969, NM_017043 and NM_001271162, accessed on February 6, 2015. Exons are numbered and their lengths indicated
along with the locations of the PCR primers used in this study. Exons are not all shown to scale. B) Representative gel showing the expression
of COX-1 (PTGS1), COX-2 (PTGS2) and HPRT1 in MDCK cells (M) and dog kidney (K). Three regions of the PTGS1 gene, namely Exon 10-11 (E10-11),
E8-9 and E4-5 were targeted for PCR amplification. The Cox1_E4-5 primers were also used to amplify genomic DNA from MDCK cells and dog
kidney, generating a larger amplicon (380 bp) due to the inclusion of a 212 bp intron. A 50-bp DNA ladder (L) is shown on the left.
Table 2 Primer sequence, location and expected amplicon sizes for dog COX-1 (PTGS1), COX-2 (PTGS2) and HPRT1
genes
Gene Accession Primer name Primer sequence Amplicon (bp) Location
PTGS1 NM_001003023 Cox1_E10-11 F TGTCCTTCCAGGAACTCACA 161 Exon10
Cox1_E10-11R GAAGGGAGCCCCAATTTCTA Exon11
PTGS1 NM_001003023 Cox1_E8-9 F ATCCTCATTGGGGAGACCAT 193 Exon8-9
Cox1_E8-9R AACCCACCCAGAAGGAGTCT Exon9
PTGS1 NM_001003023 Cox1_E4-5 F CTTTCCTCCACTTCCTGCTG 168 Exon4
Cox1_E4-5R AGAAGGACTCCCAGCTGATG Exon5
PTGS2 NM_001003354 Cox2_E6-7 F GTTCATTCCTGATCCCCAAG 186 Exon6
Cox2_E6-7R TTGAAAAGGCGCAGTTTATG Exon7
HPRT1 NM_001003357 Hprt1_F TGACACTGGGAAAACAATGCAGACT 110 Exon6
Hprt1_R AGCCAACACTTCGAGGGGTCCT Exon7
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half-life of COX-1 protein [23] results in the presence of
a residual level of this enzyme despite undetectable gene
expression. However, our failure to detect COX-1 mRNA
after 35 PCR amplification cycles suggests at best an in-
finitesimal expression and questions the biological plausi-
bility of a significant role for this enzyme in the synthesis
of pro-inflammatory prostaglandin mediators by MDCK
cells.
Despite the use of multiple primer sets (to prevent
false negative results due to faulty primers or alternative
splicing), the inclusion of a positive control for COX-1
gene expression (dog kidney mRNA), PCR amplifications
conducted for up to 35 cycles (to ensure detection of
minute expression), confirmation of amplification speci-
ficity (by sequencing of the amplicons), and additional
verifications of its inducibility (following induction of
prostaglandin synthesis in TPA-treated cells), we were
consistently unable to detect COX-1 gene expression in
MDCK cells. Hence, we reach the same conclusion as
older RT-PCR investigations predating sequencing of
dog COX-1 and COX-2 genes [11,13]. Our survey of cu-
rated dog microarray datasets at NCBI’s Gene Expres-
sion Omnibus database (www.ncbi.nlm.nih.gov/geo,
accessed on February 13, 2014) also revealed that while
COX-1 and COX-2 expression is detected in several dog
tissues (for example, see dataset GDS4164), COX-1 is
flagged as absent in MDCK cells (dataset GDS3267).
Conclusions
We conclude that in absence of detectable COX-1 gene ex-
pression, prostaglandin synthesis and associated inflam-
matory processes in MDCK cells are mediated by the
inducible COX-2 gene. However, COX-1 gene expression
in MDCK cells is sometimes assumed and the specific
COX-1 inhibitor SC-560 used [3,13,18-20,24]. Our results
clearly suggest that effects of this inhibitor in MDCK cells
are most likely independent of COX-1 inhibition [25]. This
improved characterization of cyclooxygenase expression in
MDCK cells provides new insights into the biology of this
cell line and will contribute to better experimental design
and enhanced interpretation of the results obtained.
Methods
Reagents and cell culture
The MDCK (NBL-2) cell line was purchased from
American Type Culture Collection (ATCC, Manassas,
VA, USA) in 2002, grown for a few passages and then
cryopreserved in liquid nitrogen. MDCK cell aliquots
used in this study were sub-cultured for a maximum of
15 passages. Cell culture media and fetal bovine serum
were also purchased from ATCC. MDCK cells were
grown in Eagle Minimum Essential Medium with Earle’s
Balanced Salt Solution, 10% fetal bovine serum and 1%penicillin-streptomycin (Life Technologies, Burlington,
ON, Canada) in a humidified incubator at 37°C and 5%
CO2. MDCK cells seeded at 70,000 cells/cm
2 were
allowed to grow for two days before nucleic acid
isolation.Total RNA and genomic DNA isolation
Total RNA from MDCK cells was isolated and purified
using the RNeasy kit (Qiagen, Toronto, ON, Canada).
Dog kidney total RNA was purchased from Zyagen (San
Diego, CA, USA), and further purified by RNeasy kit
after DNase treatment to avoid genomic DNA contam-
ination. RNA was quantified using a Nanodrop 1000
spectrometer (Thermo Scientific, Waltham, MA, USA)
and its integrity assessed using a 2100 Bioanalyzer (Agi-
lent Technologies, Mississauga, ON, Canada). Dog
genomic DNA was obtained from Zyagen. MDCK gen-
omic DNA was purified using Flexi Gene DNA kit
(Qiagen).Primer design and PCR amplification
Approaches for primer design and PCR amplification
were previously described [26]. Briefly, primers were de-
signed from dog PTGS1 (COX-1), PTGS2 (COX-2) and
hypoxanthine phosphoribosyltransferase 1 (HPRT1) nu-
cleotide sequences retrieved from the NCBI Refseq data-
base (Table 2). Two micrograms of total RNA were used
for first strand cDNA synthesis, using Superscript III™
reverse transcriptase (Life Technologies) and one-fifth of
the cDNA reaction or 100 ng genomic DNA was used
for gene expression analyses. PCR reactions were carried
out for 35 amplification cycles (30 s denaturation at 94°C,
30 s annealing at 60°C and 60 s extension at 72°C).
PTGS1 and PTGS2 amplification products were assessed
on agarose gels and sequenced to confirm their identities.
Gene expression assessment was performed on at least 4
different control RNA samples from another investigation
using MDCK cells [22], while assessment of MDCK gen-
omic sequence was performed on 5 different genomic
DNA samples.
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